Participants Peter Salgo, MD; John L. Fox, MD, MHA; Ira M. Klein, MD, MBA, FACP; Michael Kolodziej, MD; Bryan Loy, MD; and Irwin W. Tischler, DO, evaluate the use of quality-adjusted life-years and comparative effectiveness research (CER) to inform treatment decisions.
While it is important to measure and assess quality-adjusted life-years, Dr Kolodziej advises that finding a way to evaluate poor patient outcomes when conducting CER would provide valuable additional information. Dr Loy adds that when evaluating CER, it is imperative to understand what matters most to the various stakeholders.
Dr Tischler explains that patients and their families are often unaware of the costs of therapy. Although it is a difficult discussion to lead, it is important for clinicians to discuss cost with patients. Dr Fox adds that these discussions can help patients understand their options and what to expect. It is also important that clinicians establish trust with patients and caregivers and provide information regarding the risks and benefits of treatment, comments Dr Kolodziej. When patients with terminal diseases are fully informed about their options, most decide not to receive additional treatment, but rather to be kept comfortable, remarks Dr Fox.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More